Consult your healthcare provider for tailored medical advice. This medication is a benzodiazepine antagonist, prescribed for reversing drowsiness, sedation and other effects caused by benzodiazepine.

Long‑term benzodiazepine receptor agonist (BZRA) use for insomnia is common and highly prevalent in adults in all care settings. Evidence syntheses suggest that the therapeutic benefits of ...

an apparent dose-dependent and reversible antinociception was obtained that could be antagonized by systemic treatment with the benzodiazepine antagonist flumazenil (10 mg kg-1 ...

The anorectic actions of FG 7142 (7.5 mg/kg) were fully blocked by pretreatment with the specific benzodiazepine receptor antagonist flumazenil (10 mg/kg) (a 2:1 antagonist:agonist molar ratio ...

Therefore, the orexin receptor antagonist almorexant has the unique ... of next-day performance compared to medications targeting benzodiazepine receptors. In addition, the RESTORA program will ...